β-Lactamase inhibition by avibactam in Mycobacterium abscessus (Q38927000)

7 September 2017

β-Lactamase inhibition by avibactam in Mycobacterium abscessus (English)

1 reference

7 September 2017

Mycobacterium abscessus

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25525201%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Jean-Emmanuel Hugonnet

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25525201%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Jean-Louis Herrmann

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25525201%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Laurent Kremer

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25525201%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Michel Arthur

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25525201%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

author name string

Vincent Dubée

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25525201%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Mélanie Cortes

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25525201%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Tiffany Lesne

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25525201%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Delphine Dorchene

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25525201%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Anne-Laure Lefebvre

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25525201%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Laurent Gutmann

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25525201%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Jean-Luc Mainardi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25525201%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Jean-Louis Gaillard

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25525201%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

language of work or name

English

0 references

publication date

18 December 2014

1 reference

Journal of Antimicrobial Chemotherapy

7 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25525201%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

volume

70

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25525201%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25525201%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

page(s)

1051-1058

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25525201%20AND%20SRC:MED&resulttype=core&format=json

Proposal of Mycobacterium peregrinum sp. nov., nom. rev., and elevation of Mycobacterium chelonae subsp. abscessus (Kubica et al.) to species status: Mycobacterium abscessus comb. nov

12 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU510

Mycobacterium abscessus: a new player in the mycobacterial field

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU510

Non mycobacterial virulence genes in the genome of the emerging pathogen Mycobacterium abscessus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU510

Iatrogenic Mycobacterium abscessus infection associated with acupuncture: clinical manifestations and its treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU510

An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU510

A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU510

In vitro activity of cefoxitin and imipenem against Mycobacterium abscessus complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU510

Characterization of broad-spectrum Mycobacterium abscessus class A β-lactamase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU510

Interplay of cell wall barrier and beta-lactamase activity determines high resistance to beta-lactam antibiotics in Mycobacterium chelonae

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU510

The peptidoglycan of stationary-phase Mycobacterium tuberculosis predominantly contains cross-links generated by L,D-transpeptidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU510

Kinetic features of L,D-transpeptidase inactivation critical for β-lactam antibacterial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU510

Genetic analysis of the beta-lactamases of Mycobacterium tuberculosis and Mycobacterium smegmatis and susceptibility to beta-lactam antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU510

Crystal structure and activity studies of the Mycobacterium tuberculosis beta-lactamase reveal its critical role in resistance to beta-lactam antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU510

Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU510

Meropenem/clavulanate and linezolid treatment for extensively drug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU510

Clinical use of the meropenem-clavulanate combination for extensively drug-resistant tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU510

Overexpression of proinflammatory TLR-2-signalling lipoproteins in hypervirulent mycobacterial variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU510

Mycobacterium abscessus cording prevents phagocytosis and promotes abscess formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU510

Hypervirulence of a rough variant of the Mycobacterium abscessus type strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU510

An Unusual Acid-Fast Infection of the Knee with Subcutaneous, Abscess-Like Lesions of the Gluteal Region

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU510

Construction of Mycobacterium abscessus defined glycopeptidolipid mutants: comparison of genetic tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU510

Avibactam is a covalent, reversible, non-β-lactam β-lactamase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU510

Potential use of nitrate reductase as a biomarker for the identification of active and dormant inhibitors of Mycobacterium tuberculosis in a THP1 infection model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU510

Kinetics of avibactam inhibition against Class A, C, and D β-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU510

Irreversible inhibition of the Mycobacterium tuberculosis beta-lactamase by clavulanate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU510

NXL104 Irreversibly Inhibits the β-Lactamase from Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU510

The peptidoglycan of Mycobacterium abscessus is predominantly cross-linked by L,D-transpeptidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU510

In vivo assessment of drug efficacy against Mycobacterium abscessus using the embryonic zebrafish test system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU510

Stability of meropenem and effect of 1 beta-methyl substitution on its stability in the presence of renal dehydropeptidase I

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU510

Meropenem-clavulanic acid shows activity against Mycobacterium tuberculosis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU510

Single- and multiple-dose study to determine the safety, tolerability, and pharmacokinetics of ceftaroline fosamil in combination with avibactam in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU510

Efficacy and safety of ceftazidime-avibactam versus imipenem-cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: results of a prospective, investigator-blinded, randomized stud

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU510

Comparative study of the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infections in hospitalized adults: results of a randomized, double-blind, Phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU510